Liu CY - Search Results

1

Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.

Liu CY, Huang TT, Chen YT, Chen JL, Chu PY, Huang CT, Wang WL, Lau KY, Dai MS, Shiau CW, Tseng LM. Liu CY, et al. EBioMedicine. 2019 Feb;40:263-275. doi: 10.1016/j.ebiom.2018.12.032. Epub 2019 Jan 14. EBioMedicine. 2019. PMID: 30651219 Free PMC article.

2

Images in haematology. Pneumatosis intestinalis and pneumoperitoneum after allogeneic haematopoietic stem cell transplantation.

Huang CT, Liu CY, Wu HT, Yu YB, Tzeng CH. Huang CT, et al. Among authors: liu cy. Br J Haematol. 2010 Oct;151(2):118. doi: 10.1111/j.1365-2141.2010.08357.x. Br J Haematol. 2010. PMID: 20738300 Free article. No abstract available.

3

Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A.

Chen KF, Yu HC, Liu CY, Chen HJ, Chen YC, Hou DR, Chen PJ, Cheng AL. Chen KF, et al. Among authors: liu cy. Mol Cancer Ther. 2011 May;10(5):892-901. doi: 10.1158/1535-7163.MCT-10-0794. Epub 2011 Mar 10. Mol Cancer Ther. 2011. PMID: 21393428

4

Molluscum contagiosum in a patient with adult T-cell leukaemia/lymphoma.

Chen KW, Yang CF, Huang CT, Chiou TJ, Liu CY. Chen KW, et al. Among authors: liu cy. Br J Haematol. 2011 Nov;155(3):286. doi: 10.1111/j.1365-2141.2011.08776.x. Epub 2011 Jun 17. Br J Haematol. 2011. PMID: 21679167 Free article. No abstract available.

5

Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3.

Tai WT, Cheng AL, Shiau CW, Liu CY, Ko CH, Lin MW, Chen PJ, Chen KF. Tai WT, et al. Among authors: liu cy. Mol Cancer Ther. 2012 Feb;11(2):452-63. doi: 10.1158/1535-7163.MCT-11-0412. Epub 2011 Dec 16. Mol Cancer Ther. 2012. PMID: 22180308

6

A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation.

Chen KF, Su JC, Liu CY, Huang JW, Chen KC, Chen WL, Tai WT, Shiau CW. Chen KF, et al. Among authors: liu cy. Cancer Lett. 2012 Aug 1;321(1):27-35. doi: 10.1016/j.canlet.2012.03.023. Epub 2012 Mar 28. Cancer Lett. 2012. PMID: 22465052

7

CIP2A is a target of bortezomib in human triple negative breast cancer cells.

Tseng LM, Liu CY, Chang KC, Chu PY, Shiau CW, Chen KF. Tseng LM, et al. Among authors: liu cy. Breast Cancer Res. 2012 Apr 26;14(2):R68. doi: 10.1186/bcr3175. Breast Cancer Res. 2012. PMID: 22537901 Free PMC article.

8

Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells.

Chen KF, Lin JP, Shiau CW, Tai WT, Liu CY, Yu HC, Chen PJ, Cheng AL. Chen KF, et al. Among authors: liu cy. Biochem Pharmacol. 2012 Aug 1;84(3):268-77. doi: 10.1016/j.bcp.2012.04.023. Epub 2012 May 9. Biochem Pharmacol. 2012. PMID: 22580047

9

Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity.

Chen KF, Tai WT, Hsu CY, Huang JW, Liu CY, Chen PJ, Kim I, Shiau CW. Chen KF, et al. Among authors: liu cy. Eur J Med Chem. 2012 Sep;55:220-7. doi: 10.1016/j.ejmech.2012.07.023. Epub 2012 Jul 23. Eur J Med Chem. 2012. PMID: 22871485

10

Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody.

Chen KF, Chen HL, Shiau CW, Liu CY, Chu PY, Tai WT, Ichikawa K, Chen PJ, Cheng AL. Chen KF, et al. Among authors: liu cy. Br J Pharmacol. 2013 Feb;168(3):658-72. doi: 10.1111/j.1476-5381.2012.02212.x. Br J Pharmacol. 2013. PMID: 22978563 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,772 results

Search Page

Filters